CB-618 sodium salt structure
|
Common Name | CB-618 sodium salt | ||
---|---|---|---|---|
CAS Number | 1628207-16-8 | Molecular Weight | 312.235 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C8H10N4O6S.Na | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of CB-618 sodium saltCB-618 (CB 238618) is a novel non-β-lactam β-lactamase inhibitor that potentiates meropenem MIC values against clinical Enterobacteriaceae isolates; displays a minimal antibacterial effect alone, potentiates the meropenem MIC values of 16-512 mg/ml to 0.25-2 mg/ml. |
Name | Sodium ({[(2S,5R)-2-(1,3,4-oxadiazol-2-yl)-7-oxo-1,6-diazabicyclo[3.2.1]oct-6-yl]oxy}sulfonyl)oxidanide |
---|---|
Synonym | More Synonyms |
Description | CB-618 (CB 238618) is a novel non-β-lactam β-lactamase inhibitor that potentiates meropenem MIC values against clinical Enterobacteriaceae isolates; displays a minimal antibacterial effect alone, potentiates the meropenem MIC values of 16-512 mg/ml to 0.25-2 mg/ml. |
---|---|
References | References 1. VanScoy BD, et al. Antimicrob Agents Chemother. 2016 Jun 20;60(7):3891-6. 2. Ambrose PG, et al. Antimicrob Agents Chemother. 2017 Nov 22;61(12). pii: e00630-17. View Related Products by Target Bacterial |
Molecular Formula | C8H10N4O6S.Na |
---|---|
Molecular Weight | 312.235 |
Exact Mass | 312.014038 |
1,6-Diazabicyclo[3.2.1]octan-7-one, 2-(1,3,4-oxadiazol-2-yl)-6-(sulfooxy)-, sodium salt, (2S,5R)- (1:1) |
Sodium ({[(2S,5R)-2-(1,3,4-oxadiazol-2-yl)-7-oxo-1,6-diazabicyclo[3.2.1]oct-6-yl]oxy}sulfonyl)oxidanide |